A Phase II Open-Label Study of Ganetespib, a Novel Heat Shock Protein 90 Inhibitor for Patients With Metastatic Breast Cancer - Concepedia

Concepedia

Publication | Closed Access

A Phase II Open-Label Study of Ganetespib, a Novel Heat Shock Protein 90 Inhibitor for Patients With Metastatic Breast Cancer

100

Citations

24

References

2014

Year

Komal Jhaveri, Sarat Chandarlapaty, Diana Lake, Teresa Gilewski, Mark E. Robson, Shari Goldfarb, Pamela Drullinsky, Steven Sugarman, Carolyn Wasserheit-Leiblich, Julie Fasano,

Clinical Breast Cancer

Metastatic Breast CancerOncologyBreast OncologyMedicineImmune Checkpoint InhibitorBreast CancerAnti-cancer AgentCancer TreatmentPharmacologyRadiation Oncology

References

	Year	Citations

Page 1

Page 1